Company News

• Moderna: Covid vaccine shows nearly 95% protection

  2020 / 11 / 20

  A new vaccine that protects against Covid-19 is nearly 95% effective, early data from US company Moderna shows. The results come hot on the heels of similar results from Pfizer, and add to growing confidence that vaccines can help end the pandemic.

• Study fouses on exploring connections between ovarian cancer and blood cells

  2020 / 10 / 29

  Washington D.C.: A team of researchers collaborated to gain a better understanding of the interaction among ovarian cancer tumours, blood vessels and platelets. They found that tumours break the blood vessel barriers so that they can communicate with the blood cells, such as platelets. When these tumours come into contact with platelets, they can then metastasize, or begin to spread to other sites in the body. Dr Abhishek Jain, assistant professor in the Department of Biomedical Engineering and the Department of Medical Physiology in the College of Medicine, collaborated with researchers from the Departments of Gynecologic Oncology and Cancer Biology at MD Anderson Cancer Center for the research that was recently published in the journal Blood Advances. Currently, researchers understand that pl

• Chinese Covid-19 vaccine candidate shows promise in human trial: Study

  2020 / 10 / 19

  The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years and found that antibody responses were induced in all recipients. BEIJING: One of China's leading Covid-19 vaccine candidates, called BBIBP-CorV, was shown to be safe and elicited immune response in a small early-phase human trial, researchers said on Friday. A previous clinical trial reported similar results for a different vaccine that is also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only tested in people aged under 60 years. The latest study, published in The Lancet Infectious Diseases journal, included participants aged between 18 and 80 years, and found that antibody responses were induced in all recipients.